Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Merit Medical Systems, Inc. (MMSI) PT Lowered to $73 at Needham & Company
February 25, 2022 6:33 AM ESTNeedham & Company analyst Mike Matson lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $73.00 (from $83.00) while maintaining a Buy rating.
The analyst commented, "MMSI's 4Q21 revenue and EPS beat consensus. Revenue growth slowed slightly to 8.4% Y/Y in 4Q21 from 8.8%... More
Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 19c, Offers Guidance
February 24, 2022 4:43 PM ESTMerit Medical Systems Inc. (NASDAQ: MMSI) reported Q4 EPS of $0.71, $0.19 better than the analyst estimate of $0.52. Revenue for the quarter came in at $278.5 million versus the consensus estimate of $271.49 million.
GUIDANCE:
Merit Medical Systems Inc. sees FY2022 EPS of... More



